These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

51 related articles for article (PubMed ID: 27603903)

  • 1. Diazoxide in Children With Obesity After Hypothalamic-Pituitary Lesions: A Randomized, Placebo-Controlled Trial.
    Brauner R; Serreau R; Souberbielle JC; Pouillot M; Grouazel S; Recasens C; Zerah M; Sainte-Rose C; Treluyer JM
    J Clin Endocrinol Metab; 2016 Dec; 101(12):4825-4833. PubMed ID: 27603903
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High-Dose, Diazoxide-Mediated Insulin Suppression Boosts Weight Loss Induced by Lifestyle Intervention.
    Loves S; van Groningen L; Filius M; Mekking M; Brandon T; Tack CJ; Hermus A; de Boer H
    J Clin Endocrinol Metab; 2018 Nov; 103(11):4014-4022. PubMed ID: 30202851
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diazoxide-mediated insulin suppression in obese men: a dose-response study.
    Schreuder T; Karreman M; Rennings A; Ruinemans-Koerts J; Jansen M; de Boer H
    Diabetes Obes Metab; 2005 May; 7(3):239-45. PubMed ID: 15811140
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of Diazoxide-Mediated Insulin Suppression on Glucose and Lipid Metabolism in Nondiabetic Obese Men.
    Loves S; van Groningen L; Filius M; Mekking M; Brandon T; Tack CJ; Hermus A; de Boer H
    J Clin Endocrinol Metab; 2018 Jun; 103(6):2346-2353. PubMed ID: 29618011
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Octreotide therapy of pediatric hypothalamic obesity: a double-blind, placebo-controlled trial.
    Lustig RH; Hinds PS; Ringwald-Smith K; Christensen RK; Kaste SC; Schreiber RE; Rai SN; Lensing SY; Wu S; Xiong X
    J Clin Endocrinol Metab; 2003 Jun; 88(6):2586-92. PubMed ID: 12788859
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy and safety of the dipeptidyl peptidase-4 inhibitor sitagliptin added to ongoing pioglitazone therapy in patients with type 2 diabetes: a 24-week, multicenter, randomized, double-blind, placebo-controlled, parallel-group study.
    Rosenstock J; Brazg R; Andryuk PJ; Lu K; Stein P;
    Clin Ther; 2006 Oct; 28(10):1556-68. PubMed ID: 17157112
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of sibutramine in overweight adult hispanic patients with type 2 diabetes mellitus: a 12-month, randomized, double-blind, placebo-controlled clinical trial.
    Sánchez-Reyes L; Fanghänel G; Yamamoto J; Martínez-Rivas L; Campos-Franco E; Berber A
    Clin Ther; 2004 Sep; 26(9):1427-35. PubMed ID: 15531005
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prolonged hyperglycemia & hyperinsulinemia increases BDNF mRNA expression in the posterior ventromedial hypothalamus and the dorsomedial hypothalamus of fed female rats.
    Negrón AL; Beymer M; Yu G; Warren KA; Acosta-Martínez M
    Neuroscience; 2015 Sep; 303():422-32. PubMed ID: 26166726
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacology and tolerability of a single dose of exenatide in adolescent patients with type 2 diabetes mellitus being treated with metformin: a randomized, placebo-controlled, single-blind, dose-escalation, crossover study.
    Malloy J; Capparelli E; Gottschalk M; Guan X; Kothare P; Fineman M
    Clin Ther; 2009 Apr; 31(4):806-15. PubMed ID: 19446153
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of Liraglutide for Weight Loss Among Patients With Type 2 Diabetes: The SCALE Diabetes Randomized Clinical Trial.
    Davies MJ; Bergenstal R; Bode B; Kushner RF; Lewin A; Skjøth TV; Andreasen AH; Jensen CB; DeFronzo RA;
    JAMA; 2015 Aug; 314(7):687-99. PubMed ID: 26284720
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of differential effects of metformin treatment in obese children according to pubertal stage and genetic variations: study protocol for a randomized controlled trial.
    Pastor-Villaescusa B; Caballero-Villarraso J; Cañete MD; Hoyos R; Maldonado J; Bueno G; Leis R; Gil Á; Cañete R; Aguilera CM
    Trials; 2016 Jul; 17(1):323. PubMed ID: 27432166
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Beneficial effect of diazoxide in obese hyperinsulinemic adults.
    Alemzadeh R; Langley G; Upchurch L; Smith P; Slonim AE
    J Clin Endocrinol Metab; 1998 Jun; 83(6):1911-5. PubMed ID: 9626118
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Low-dose combination therapy with rosiglitazone and metformin to prevent type 2 diabetes mellitus (CANOE trial): a double-blind randomised controlled study.
    Zinman B; Harris SB; Neuman J; Gerstein HC; Retnakaran RR; Raboud J; Qi Y; Hanley AJ
    Lancet; 2010 Jul; 376(9735):103-11. PubMed ID: 20605202
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Therapeutic Effects of Butyrate on Pediatric Obesity: A Randomized Clinical Trial.
    Coppola S; Nocerino R; Paparo L; Bedogni G; Calignano A; Di Scala C; de Giovanni di Santa Severina AF; De Filippis F; Ercolini D; Berni Canani R
    JAMA Netw Open; 2022 Dec; 5(12):e2244912. PubMed ID: 36469320
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Classically Cardioprotective Agent Diazoxide Elicits Arrhythmias in Type 2 Diabetes Mellitus.
    Xie C; Hu J; Motloch LJ; Karam BS; Akar FG
    J Am Coll Cardiol; 2015 Sep; 66(10):1144-1156. PubMed ID: 26337994
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metformin in obese children and adolescents: the MOCA trial.
    Kendall D; Vail A; Amin R; Barrett T; Dimitri P; Ivison F; Kibirige M; Mathew V; Matyka K; McGovern A; Stirling H; Tetlow L; Wales J; Wright N; Clayton P; Hall C
    J Clin Endocrinol Metab; 2013 Jan; 98(1):322-9. PubMed ID: 23175691
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Linagliptin, a dipeptidyl peptidase-4 inhibitor in development for the treatment of type 2 diabetes mellitus: a Phase I, randomized, double-blind, placebo-controlled trial of single and multiple escalating doses in healthy adult male Japanese subjects.
    Sarashina A; Sesoko S; Nakashima M; Hayashi N; Taniguchi A; Horie Y; Graefe-Mody EU; Woerle HJ; Dugi KA
    Clin Ther; 2010 Jun; 32(6):1188-204. PubMed ID: 20637971
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Safety and efficacy of low-dose diazoxide in small-for-gestational-age infants with hyperinsulinaemic hypoglycaemia.
    Chandran S; R PR; Mei Chien C; Saffari SE; Rajadurai VS; Yap F
    Arch Dis Child Fetal Neonatal Ed; 2022 Jul; 107(4):359-363. PubMed ID: 34544689
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metformin in women with type 2 diabetes in pregnancy (MiTy): a multi-center randomized controlled trial.
    Feig DS; Murphy K; Asztalos E; Tomlinson G; Sanchez J; Zinman B; Ohlsson A; Ryan EA; Fantus IG; Armson AB; Lipscombe LL; Barrett JF;
    BMC Pregnancy Childbirth; 2016 Jul; 16(1):173. PubMed ID: 27435163
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of pioglitazone on bone in postmenopausal women with impaired fasting glucose or impaired glucose tolerance: a randomized, double-blind, placebo-controlled study.
    Bone HG; Lindsay R; McClung MR; Perez AT; Raanan MG; Spanheimer RG
    J Clin Endocrinol Metab; 2013 Dec; 98(12):4691-701. PubMed ID: 24057294
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.